Cilostazol
KOP-PLT-0501
Approved small_molecule completed
Quick answer
Cilostazol for Cerebral Infarction is a Approved program (small_molecule) at Otsuka Beijing Research Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Beijing Research Institute
- Indication
- Cerebral Infarction
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed